Abstract:Background Puerarin (Pue) is an isoflavone compound with significant therapeutic effect on cardiovascular diseases, but its poor water solubility and low oral bioavailability limit clinical application. Methods In this study, Pue was prepared into PLGA nanoparticles (Pue-PLGA NPs) by emulsion solvent volatilization method. The morphology, particle size, Zeta potential, X-ray diffraction (XRD), and fourier transform infrared (FTIR) of the NPs were characterized. Additionally, their stability and in vitro release were evaluated. SD rats were orally administered wtih Pue and Pue-PLGA NPs, and a high performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was established to determine the concentration of blood samples and to investigate the pharmacokinetic behaviour of Pue and Pue-PLGA NPs in rats. Results The NPs were observed by transmission electron microscopy (TEM) as regular spheroids and uniformly dispersed. The average particle size of the NPs was (167.1±5.26）nm, the Zeta potential was (-29.88±2.46)mV, the encapsulation rate was (83.12 %±4.73 %) and the drug loading capacity was (7.75 %±1.81 %). The results of in vitro release showed that the drug was released slowly and continuously from the NPs, reaching the release platform in 24 h, and the cumulative release amount was (88.55±2.86) %. The pharmacokinetic results showed that the AUC0–24, AUC0-∞, Cmax, Tmax, t1/2, MRT0–24 and MRT0-∞ of Pue-PLGA NPs were 2.196, 1.978, 1.327, 1.5, 1.385, 3.915 and 3.140 times of Pue, respectively. The relative bioavailability was (197.82±25.28) %. Conclusion These results indicated that the prepared nanoparticles had small particle size, high encapsulation rate, drug loading capacity and good slow-release effect, and could significantly improve the oral bioavailability of Pue in rats.

Preparation of puerarin solid lipid nanoparticles for oral administration

Preparation and Characterization of Puerarin-Loaded Lipid Nanocapsules

Preparation and Evaluation of Puerarin-loaded PLGA Nanoparticles for Improving Oral Bioavailability in SD Rats

Preparation, characterization and bioavailability of oral puerarin nanoparticles by emulsion solvent evaporation method

Preparation, Characterization And Drug Release Of Biodegradable Solid Lipid Nanoparticles

Studies on crystallinity state of puerarin loaded solid lipid nanoparticles prepared by double emulsion method

Optimization of the Formula for Puerarin Flavonoids Solid Lipid Nanoparticle by Central Design-Response Surface Method

Study on Preparation of Puerarin Proliposomes and Its Pharmaceutical Characteristics in Vitro

Preparation and Release Rate in Vitro of Puerarin Enteric Nanoparticles

Enhancement of Oral Bioavailability of Puerarin by Polybutylcyanoacrylate Nanoparticles

Preparation and Quality Evaluation of Brucine Solid Lipid Nanoparticles

Preparation of Solid Lipid Nanoparticles Containing Praziquantel

Preparation Technology of Curcumine Solid Lipid Nanoparticles

Preparation of Puerarin Chitosan Nanoparticles

Preparation of Puerarin Liposomes for Injection and Determination of Its Entrapment Efficiency

Preparation and characterization of solid lipid nanoparticles loaded traditional Chinese medicine.

Preparation of Liriope Muscari Baily Saponins C Solid Lipid Nanoparticles

Supercritical Assisted Atomization for Preparation of Solid Lipid Nanoparticles

Preparation of Actarit Solid Lipid Nanoparticles

Preparation of Solid Lipid Nanoparticles by Emulsification-evaporation Technique

Preparation of oridonin-loaded solid lipid nanoparticles and studies on them in vitro and in vivo